[144] Olema Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

OLMA reports an insider sale filing: Shane W. Kovacs intends to sell 100,000 shares of Common Stock pursuant to an option (Option Granted 02/01/2023), with the sale noted for 03/16/2026.

The filing also lists multiple recent dispositions by Kovacs during the past three months, including sales of 241,999 shares on 03/09/2026 and 100,000 shares on 01/15/2026, each with the cash amounts shown in the record.

Insights

Insider Transactions Analyst

Routine large-scale dispositions by a reporting holder; contextualize scale versus total holdings.

The filing shows Shane W. Kovacs reporting an intended sale of 100,000 shares under an option exercisable from an award granted on 02/01/2023. The entry is a disposition report and lists execution via cash.

The record also lists multiple open-market dispositions across 01/13/2026–03/11/2026, including a 241,999-share sale on 03/09/2026. Subsequent filings may clarify remaining holdings; cash-flow treatment to the issuer or holder is shown per-row as cash.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	100000	1607718.55	87156961	03/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2026	Option Granted - 02/01/2023	Issuer			100000	03/16/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	01/13/2026	3822	107069.20
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	01/15/2026	100000	2873214.99
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/12/2026	10000	238498.19
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/23/2026	30000	723007.46
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/24/2026	20000	500002.00
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/27/2026	6521	163026.25
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	03/04/2026	20000	488653.67
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	03/09/2026	241999	3254934.55
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	03/10/2026	53206	904566.21
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	03/11/2026	50000	796795.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)